We are live on ! Find out more
RAM

Readystate Asset Management Portfolio holdings

AUM $2.23B
1-Year Est. Return 15%
This Fund
S&P 500
This Quarter Est. Return
+3.66%
1 Year Est. Return
+15%
3 Year Est. Return
+34.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.47B
AUM Growth
+$120M
Cap. Flow
-$597M
Cap. Flow %
-24.21%
Top 10 Hldgs %
35.85%
Holding
508
New
164
Increased
83
Reduced
61
Closed
122

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$251M
2
HSY icon
Hershey
HSY
+$72.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$37.9M
4
SLNO
Soleno Therapeutics
SLNO
+$36.7M
5
PAR icon
PAR Technology
PAR
+$15.9M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$49.2M
2
WK icon
Workiva
WK
+$32M
3
VRNA
Verona Pharma
VRNA
+$28M
4
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$27.6M
5
SPR
Spirit AeroSystems
SPR
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 10.36%
2 Technology 6.53%
3 Consumer Staples 4.75%
4 Consumer Discretionary 3.3%
5 Communication Services 2.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HVMCW
351
Highview Merger Corp Warrants
HVMCW
$4.14M
$3.05K ﹤0.01%
+11,290
New +$3.75K
NAMMW
352
Namib Minerals Warrants
NAMMW
$3.69M
$1.79K ﹤0.01%
25,000
– –
ADX icon
353
Adams Diversified Equity Fund
ADX
$3.05B
– –
-32,106
Closed -$716K
AKRO
354
DELISTED
Akero Therapeutics
AKRO
– –
-237,908
Closed -$11.3M
ALGS icon
355
Aligos Therapeutics
ALGS
$25.9M
– –
-203,113
Closed -$1.99M
AMLX icon
356
Amylyx Pharmaceuticals
AMLX
$2.19B
– –
-59,132
Closed -$804K
AOR icon
357
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.63B
– –
-6,120
Closed -$394K
APLS
358
DELISTED
Apellis Pharmaceuticals
APLS
– –
-241,977
Closed -$5.48M
ASND icon
359
Ascendis Pharma A/S
ASND
$16.6B
– –
-15,570
Closed -$3.1M
AXSM icon
360
Axsome Therapeutics
AXSM
$11.8B
– –
-17,860
Closed -$2.17M
BA icon
361
PUT
Boeing
BA
$169B
– –
-70,000
Closed -$15.1M
BBIO icon
362
BridgeBio Pharma
BBIO
$16.6B
– –
-117,379
Closed -$6.1M
BBN icon
363
BlackRock Taxable Municipal Bond Trust
BBN
$979M
– –
-49,659
Closed -$824K
BEAM icon
364
Beam Therapeutics
BEAM
$2.73B
– –
-93,930
Closed -$2.28M
BINC icon
365
BlackRock Flexible Income ETF
BINC
$16.1B
– –
-187,500
Closed -$9.98M
BLW icon
366
BlackRock Limited Duration Income Trust
BLW
$489M
– –
-10,715
Closed -$150K
BME icon
367
BlackRock Health Sciences Trust
BME
$570M
– –
-6,896
Closed -$257K
BYM
368
DELISTED
BlackRock Municipal Income Quality Trust
BYM
– –
-13,301
Closed -$146K
CDTX
369
DELISTED
Cidara Therapeutics
CDTX
– –
-20,532
Closed -$1.97M
CHW
370
Calamos Global Dynamic Income Fund
CHW
$523M
– –
-35,725
Closed -$269K
CHY
371
Calamos Convertible and High Income Fund
CHY
$975M
– –
-14,657
Closed -$164K
CIVI
372
DELISTED
Civitas Resources
CIVI
– –
-88,844
Closed -$2.89M
CLDX icon
373
Celldex Therapeutics
CLDX
$2.86B
– –
-46,520
Closed -$1.2M
COGT icon
374
Cogent Biosciences
COGT
$6.75B
– –
-49,692
Closed -$714K
COOP
375
DELISTED
Mr. Cooper
COOP
– –
-87,000
Closed -$18.3M
13 14
15
16 17

Similar funds

DPCM
Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.22B AUM 20.66% 1-Year Est. Return
NP
NS Partners London, United Kingdom $2.23B AUM 20.03% 1-Year Est. Return
ML
McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
NLGIA
Nippon Life Global Investors Americas New York $2.22B AUM 30.05% 1-Year Est. Return
BOI
Bank of Italy Rome, Italy $2.21B AUM 9.01% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return

Readystate Asset Management's Q4 2025 Portfolio in Review

As of Q4 2025, Readystate Asset Management held 508 positions worth $2.47B, up 5.1% from $2.35B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Readystate Asset Management withdrew a net $597M in Q4 2025, closing 122 positions and reducing 61 holdings. Its most notable exit was Verona Pharma, an estimated $28M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Readystate Asset Management opened a new position in iShares Core S&P 500 ETF worth $253M.

  • Readystate Asset Management's largest Q4 2025 buy was iShares Core S&P 500 ETF: 369,000 shares worth $253M.
  • Readystate Asset Management added most to Soleno Therapeutics in Q4 2025, an estimated $36.7M increase.
  • Readystate Asset Management's biggest Q4 2025 reduction was Exact Sciences, cutting an estimated $49.2M.
  • Readystate Asset Management fully exited Verona Pharma in Q4 2025, selling an estimated $28M.
  • Readystate Asset Management's ten largest holdings make up 36% of its $2.47B portfolio in Q4 2025.
  • Readystate Asset Management opened 164 new positions and closed 122 in Q4 2025.
  • Readystate Asset Management's portfolio value rose 5.1% quarter-over-quarter to $2.47B.

Based on Readystate Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.